// App-Quantinova.ai

: PREDICTIVE FACTORS OF CARDIOTOXICITY IN LYMPHOMA PATIENTS RECEIVING ANTHRACICLINES IN THE FIRST LINE TREATMENT

Researchers

Presenter

  • Alberto Lopez-Garcia

Principal Investigators

  • Ester Macia

  • Sandra Talavera

  • Miguel Orejas

  • Borja Ibaez

  • Eva Castillo

  • Daniel Morillo

  • Maria-Angeles Perez

  • Francisco Lobo

  • Elham Askari

  • Elena Prieto

  • Pilar Llamas

  • Cristina Fernandez

  • Raul Cordoba

Medical Centers

  • Hematology Service, Hospital Clinico San Carlos, Madrid, Spain

  • Oncology, Fundación Jiménez Díaz, Madrid, Spain

  • Pharmacy,Fundacion Jimenez Diaz,Madrid,Spain

  • Oncology, Fundación Jiménez Díaz, Madrid, Spain

  • Immunology,Hospital clinico San Carlos,Madrid,Spain

Locations

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

  • Oncology (ONC)

Disease

  • Coronary Artery Disease

  • Venous thrombosis

  • Cardiotoxicity

  • Congestive heart failure

  • Lymphomas

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved